Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Inventory Average (2016 - 2025)

Heron Therapeutics (HRTX) has disclosed Inventory Average for 10 consecutive years, with $71.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average rose 61.0% year-over-year to $71.5 million, compared with a TTM value of $71.5 million through Sep 2025, up 61.0%, and an annual FY2024 reading of $47.6 million, down 1.46% over the prior year.
  • Inventory Average was $71.5 million for Q3 2025 at Heron Therapeutics, up from $64.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $71.5 million in Q3 2025 and bottomed at $21.1 million in Q1 2024.
  • Average Inventory Average over 5 years is $47.8 million, with a median of $48.3 million recorded in 2023.
  • The sharpest move saw Inventory Average tumbled 60.42% in 2024, then surged 202.34% in 2025.
  • Year by year, Inventory Average stood at $44.9 million in 2021, then rose by 18.83% to $53.4 million in 2022, then dropped by 21.25% to $42.1 million in 2023, then increased by 17.82% to $49.6 million in 2024, then surged by 44.27% to $71.5 million in 2025.
  • Business Quant data shows Inventory Average for HRTX at $71.5 million in Q3 2025, $64.9 million in Q2 2025, and $55.0 million in Q1 2025.